A pituitary tumour is almost always benign, meaning it is non-cancerous and does not spread to other parts of the body. However, the term “benign” can be misleading when it comes to the pituitary gland. Because this gland is the master controller of the body’s endocrine system, even a non-cancerous growth can cause significant and sometimes life-altering hormonal disruptions. These problems arise either because the tumour itself pumps out excessive amounts of hormones or because its physical size prevents the healthy part of the gland from working correctly. In the delicate environment of the brain, a benign growth can still be a serious clinical issue that requires medical intervention to restore the body’s chemical balance.
What We’ll Discuss in This Article
- The difference between functioning and non-functioning benign tumours.
- How hormone overproduction leads to conditions like acromegaly or Cushing’s disease.
- The impact of tumour size on healthy hormone production (hypopituitarism).
- Common symptoms of hormonal imbalance caused by benign growths.
- The relationship between pituitary tumours and secondary gland failure.
- Treatment options focused on restoring hormonal stability.
Functioning Tumours and Hormone Excess
Many benign pituitary tumours are “functioning” adenomas, which means the tumour cells actively produce hormones. Because these cells do not respond to the body’s normal “off” switches, they continue to release hormones into the bloodstream regardless of what the body actually needs. Even a tiny microadenoma, less than one centimetre in size, can cause major health problems if it is hormonally active.
One of the most common examples is a prolactinoma, which produces too much prolactin. This can lead to infertility, a loss of sex drive, and unexpected breast milk production. Another example is a tumour that produces growth hormone, leading to acromegaly, where the bones and tissues of the hands, feet, and face grow excessively. Because these hormones affect nearly every system in the body, the “benign” nature of the tumour does not prevent it from causing systemic illness. The NHS provides detailed information on how functioning tumours are diagnosed and managed through hormone suppression or surgery.
The Impact on the Master Control System
The pituitary gland acts as a central hub for the body’s “axes” the communication lines between the brain and other organs. When a benign tumour disrupts this hub, the effects are widespread. For instance, the hypothalamic-pituitary-adrenal axis is responsible for the body’s stress response. If a tumour disrupts this line, a person may lose the ability to regulate their blood pressure or energy levels during illness.
Similarly, the hypothalamic-pituitary-gonadal axis controls reproductive health. A benign tumour can cause a drop in oestrogen or testosterone, leading to bone density loss (osteoporosis) and a higher risk of heart disease over time. These are “major” health problems that stem from a growth that is technically non-cancerous. Clinicians often focus more on the hormonal “output” of the patient than the benign label of the tumour itself when deciding how urgently to treat the condition.
Recognizing the Symptoms of Hormonal Disruption
Because benign pituitary tumours affect so many different hormones, the symptoms can be incredibly varied and may appear unrelated at first. Some of the major hormonal problems manifested through symptoms include:
- Unexplained weight gain or loss: Often linked to disruptions in thyroid or adrenal hormones.
- Extreme fatigue and muscle weakness: Caused by low cortisol or growth hormone deficiency.
- Changes in vision: While not hormonal, this occurs when a large tumour presses on the optic nerves.
- Mood changes and cognitive fog: Often a result of global hormone imbalances affecting brain chemistry.
- Skin and hair changes: Such as thinning skin, easy bruising, or unexpected hair growth or loss.
These symptoms often develop slowly over months or years, meaning many patients adapt to feeling unwell before realizing there is an underlying medical cause. Early blood tests to check the full range of pituitary hormones are essential for identifying these “silent” hormonal problems.
Secondary Gland Failure and Systemic Health
A significant complication of a benign pituitary tumour is secondary gland failure. This is when the target glands—the thyroid, adrenals, and gonads—are physically healthy but stop working because the pituitary gland is no longer sending them the necessary instructions. For example, a patient may be diagnosed with an underactive thyroid, but the root cause is actually a benign tumour in the brain.
This secondary failure is particularly dangerous when it affects the adrenal glands. Cortisol is essential for life, and a sudden drop in its production can lead to an adrenal crisis. This is a medical emergency that can cause extremely low blood pressure, vomiting, and loss of consciousness. Therefore, managing a benign pituitary tumour is not just about the tumour itself, but about safeguarding the function of all the other gland systems in the body.
Treatment Goals: Restoring Hormonal Balance
The goal of treating a benign pituitary tumour is almost always twofold: to stop the growth (or remove it) and to restore a healthy hormonal balance. In some cases, such as with prolactinomas, medication can be used to shrink the tumour and normalize hormone levels without the need for surgery. For other tumours, surgery is required to remove the mass and take the pressure off the healthy pituitary tissue.
If the healthy part of the gland has been permanently damaged, patients may need lifelong hormone replacement therapy. This involves taking synthetic versions of the missing hormones to ensure the thyroid, adrenals, and reproductive systems continue to function. The NICE guidelines for pituitary adenomas emphasize the importance of long-term follow-up to monitor these hormone levels and adjust medication as needed.
Conclusion
A benign pituitary tumour can absolutely cause major hormonal problems. Whether through the overproduction of hormones or the physical suppression of healthy gland tissue, these non-cancerous growths can disrupt the body’s metabolism, stress response, and reproductive health. While the tumours are not “cancer,” their impact on the endocrine system requires careful medical management to prevent long-term health complications. If you experience severe, sudden, or worsening symptoms such as extreme confusion, fainting, or a severe headache, call 999 immediately.
If it’s benign, does that mean it won’t grow back?
Most benign tumours do not grow back if fully removed, but some can recur, which is why regular follow-up MRI scans and blood tests are necessary.
Can a benign tumour cause me to lose my sight?
Yes, if the tumour grows large enough (a macroadenoma), it can press on the optic nerves, leading to a permanent loss of peripheral vision if not treated.
Do all benign pituitary tumours need surgery?
No, many small tumours (microadenomas) that aren’t causing symptoms or hormone excess can be monitored with a “watch and wait” approach.
Can a tumour make me feel depressed or anxious?
Yes, hormone imbalances caused by pituitary tumours can significantly affect your mood, energy levels, and overall mental well-being.
Will I always have to take hormone pills?
It depends; if the healthy part of your gland recovers after treatment, you may not need them, but many patients require some form of long-term replacement.
Can these tumours be inherited?
Most occur randomly, but in rare cases, they can be part of a genetic condition like Multiple Endocrine Neoplasia type 1 (MEN1).
How common are these tumours?
They are relatively common, with some studies suggesting up to one in six people may have a tiny, harmless pituitary growth they never know about.
Authority Snapshot (E-E-A-T Block)
This article explores the significant clinical impact that non-cancerous pituitary growths can have on the human body. It has been authored by the medical content team and reviewed by Dr. Rebecca Fernandez to ensure the information is accurate and reflects current UK medical standards. The content is strictly based on NHS and NICE guidance for the diagnosis and management of pituitary disorders.
